Category Archives: Hepatitis C


CDC Reports that new cases of Hepatitis C increased by 22% in 2016

Last week, the Centers for Disease Control and Prevention (CDC) released the 2016 Surveillance Report for Viral Hepatitis. The report states that new cases of hepatitis C actually reported to the CDC rose from 2,436 in 2015 to 2,967 in 2016, and the estimated number of new infections increased from 33,900 in 2015 to 41,200 […]

Read More

Posted in Hepatitis C, Hepatitis C News and Research;


Elimination Without Prevention — Mission Impossible

This article was written by Thelma Thiel, Founder and Chair of the Liver Health Initiative. Viewpoints included in this article do not necessarily reflect those of the O’Neill Institute, the Hepatitis Policy Project or its sponsors.  All the media attention highlighting the dramatic increase in opioid and other drug addition, as well as the rising […]

Read More

Posted in Hepatitis C, Uncategorized; Tagged: .


Low Rates of Screening for Hepatitis C Still Persists Among Baby Boomers

This blog post was authored by Dr. Daniel Lising, Research Assistant for the O’Neill Institute’s Hepatitis Policy Project. Daniel is an LLM in Global Health student at Georgetown University Law Center. According to the CDC, approximately 2.7 to 3.9 million people are chronically infected with Hepatitis C (HCV) and of every 100 persons infected, 1 […]

Read More

Posted in Hepatitis C, Hepatitis C Staff Insights, Uncategorized;


Actions Speak Louder than Words: Reclaiming Lost Ground in the Battles Against Viral Hepatitis

Expert Columnist post for the Hepatitis Policy Project at the O’Neill Institute for National and Global Health Law Written by Richard J. Wolitski, PhD, Director, and Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services Viral hepatitis […]

Read More

Posted in Hepatitis C; Tagged: .


The Silent Epidemic of Hepatitis C in the United States

This blog post was authored by Dr. Daniel Lising, Research Assistant for the O’Neill Institute’s Hepatitis Policy Project. Daniel is an LLM in Global Health student at Georgetown University Law Center. In recent months, the spotlight has been trained on the alarming opioid crisis and even the President of the United States declaring it to […]

Read More

Posted in Hepatitis C, Hepatitis C Staff Insights;


Archives

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.